Advancing the treatment for chagas' disease

New England Journal of Medicine

Volumn 370, Issue 20, 2014, Pages 1942-1943

  Albajar Vinãs, Pedro ^a   Dias, João Carlos P ^a,b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX; POSACONAZOLE;

CHAGAS DISEASE; CLINICAL EFFECTIVENESS; DISEASE COURSE; DISEASE DURATION; DRUG ACTIVITY; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEALTH CARE ACCESS; HUMAN; NONHUMAN; PARASITE CONTROL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT PLANNING; TREATMENT RESPONSE; TRYPANOSOMA CRUZI; UNSPECIFIED SIDE EFFECT;

CHAGAS DISEASE; FEMALE; HUMANS; MALE; NITROIMIDAZOLES; TRIAZOLES; TRYPANOCIDAL AGENTS;

EID: 84900341815     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1403689     Document Type: Editorial

References (10)

1. Molina I, Gómez i Prat J, Salvador F, et al. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. N Engl J Med 2014;370:1899-908.
2. Rodriques Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002;97:3-24.
3. Cançado JR. Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop Sao Paulo 2002;44:29-37. (Pubitemid 34205107)
4. Rassi A. Etiological treatment of Chagas' disease. Arq Bras Cardiol 1982;38:277-81. (In Portuguese.)
5. Miranda L, Miranda I, Campos G, Marins N, Lobo V. História natural da forma crônica da doença de Chagas x tratamento específico. Rev Centro-Oeste Cardiol 1994;1:25-9.
6. Viotti R, Vigliano C, Armenti H, Segura E. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 1994;127:151-62. (Pubitemid 24040442)
7. Fragata Filho AA, da Silva MA, Boainain E. Ethiologic treatment of acute and chronic Chagas' disease. Sao Paulo Med J 1995;113:867-72.
8. Yun O, Lima MA, Ellman T, et al. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières. PLoS Negl Trop Dis 2009;3(7):e488.
9. Dias JC, Dias E, Martins-Filho OA, et al. Further evidence of spontaneous cure in human Chagas disease. Rev Soc Bras Med Trop 2008;41:505-6.
10. Dias JCP, Coura JR, Yasuda MAS. The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease. Rev Soc Bras Med Trop 2014;47:123-5.